Ion sensor for long term use in complex medium

• US 8,055,322 B2
• Filed: 02/21/2008
• Issued: 11/08/2011
• Est. Priority Date: 07/30/2004
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Ye, Qingshan
• Primary Examiner(s): Marmor, II; Charles A
• Assistant Examiner(s): TOTH, KAREN E
• Application Number:
  US12/035,052
• Publication Number:
  US 20080161665A1
• Time in Patent Office: 1,356 Days
• Field of Search: 600/309, 600/345, 600/348
• US Class Current: 600/348
• CPC Class Codes: A61B 5/14542 for measuring blood gases A61B5/14551 takes precedence
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1473 invasive, e.g. introduced into the body by a catheter A61B5/1482 takes precedence

Abstract

Devices and methods for measuring a target ion concentration uses an electrode pair. The pair includes a working electrode and a reference electrode. The working and reference electrodes are ion-selective electrodes (ISEs). The reference ISE can include a sodium ISE. The ISE pair interacts with body fluids where a target ion concentration changes more than sodium ion concentration over time. Some ISE membranes of a pair vary essentially only in the ionophore. An ISE pair can determine the ratio of a target ion concentration to sodium ion concentration in vivo. Periodic measurement of sodium concentration in drawn blood can be used to calibrate an ISE pair and provide target ion concentration as an output. Or, a potassium/sodium ISE pair beneficially monitors potassium concentration changes over time in heart- or kidney-failure patients. Then, manual or automatic titration of a diuretic material can be implemented to maintain a desired potassium concentration.

Claims

1. A method for detecting ischemia comprising:

obtaining a differential electrical potential between an implanted electrode pair in a human body, the electrode pair including a first ion selective electrode (ISE) and a sodium ISE, wherein first ISE is a potassium ISE; and

employing an implanted medical device to generate an indication of ischemia at least in part as a function of a change in the differential electrical potential over time, wherein the change is a rise in a ratio of potassium to sodium over time.

2. A method according to claim 1, in which the obtaining includes the electrode pair being implanted in a heart in the human body.

3. A method according to claim 1, in which the ischemia detected is a cardiac infarction.

4. A method according to claim 1, in which the ischemia detected takes place in a brain in the human body.

5. A method according to claim 1, wherein at least one of the first ISE and the sodium ISE are adapted to be disposed at least partially in a region of relatively high fluid flow.

6. A method according to claim 5, wherein said region of relatively high fluid flow comprises a portion of:

a Superior Vena Cava vessel, an Inferior Vena Cava vessel, a right ventricular outflow tract.